biotech
biotech Articles
Clinical-stage, drug platform company Annovis Bio entered the market with a bang on Wednesday.
Published:
The January 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
If there is one group that can produce stock gains regardless of the daily market activities, that would be biotechnology and emerging pharmaceuticals. Coming up with a new approach or new way to...
Published:
These three health care companies included are expected to report their earnings on Tuesday morning.
Published:
As with almost all pandemic scares and other national and global issues, some speculative stocks manage to see their shares rise sharply.
Published:
The Wuhan Coronavirus has already left China and hit neighboring countries, the U.S. and even in Europe in Australia. As the death toll and number of infected are rising each hour, the economic...
Published:
Last Updated:
Why Credit Suisse believes that this round of quarterly biotech earnings could prove to be a catalyst for 2020.
Published:
New research shows that several members of the coronavirus family are susceptible to inactivation via a system developed by biomedical products company Cerus.
Published:
Applied Genetic Technologies' shares were crushed early on Thursday after the firm reported interim data from its midstage trial in patients with achromatopsia.
Published:
Akcea Therapeutics and Ionis Pharmaceuticals each made handy gains on Wednesday after the firms reported midstage results for their cardiovascular disease study.
Published:
Neurotrope released a corporate update after analyzing data from its recently reported Phase 2 confirmatory clinical trial examining moderately severe to severe Alzheimer's disease patients.
Published:
China is facing an outbreak of the coronavirus, which may have spread to a few other countries in Asia. As a result, experimental vaccine stocks are skyrocketing.
Published:
When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout or an extremely positive change in a company's future prospects. For Genprex, it was a nod from...
Published:
For health care investors, 2020 looks like a potentially good year after an especially fruitful JPMorgan Healthcare Conference this past week.
Published:
This past week played host to a huge number of biotech movers. 24/7 Wall St. has picked a few of these standouts to highlight.
Published: